Innovation in Switzerland’s pharmaceutical industry has fallen for the second year in a row, a new study shows, underscoring how it is trailing foreign competitors in digital research and clinical trials.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.